Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Pregnancy is accompanied by profound changes in the body. Among other things, these affect the energy metabolism and the ...

Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Mar. 18, 2024 — Scientists have developed the first wireless, implantable temperature sensor to detect inflammatory flareups in patients with Crohn's disease. The approach offers long-term ...

The groundbreaking study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in ...

Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...

The leading Crohn's Disease companies such as Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, ...

Crohn’s Disease is a chronic inflammatory bowel disease, and one-third of patients have no response to initial treatment with tumor necrosis factor (TNF) antagonists. Some patients have a very ...

Severely ill and distressed patients are waiting three and a half days in emergency for mental health beds that don’t exist in a shocking escalation of the state’s psychiatrist workforce crisis.

In four countries, 22 patients who completed the study opted ... trials in other inflammatory indications including Crohn’s disease.” Ulcerative colitis is a debilitating inflammatory bowel ...